![United States: FDA Approves First Cellular Therapy For Treatment Of Unresectable Or Metastatic Melanoma - Goodwin Procter LLP](https://cdn.newsserve.net/ONPglobe256.png)
United States: FDA Approves First Cellular Therapy For Treatment Of Unresectable Or Metastatic Melanoma - Goodwin Procter LLP
On February 16, 2024, the FDA approved Iovance's AMTAGVI, the first approved cellular therapy for the treatment of adult patients with unresectable or metastatic melanoma.
Full Article